瘤标记物的未来:通过Omics技术,持续监测和个性化参考间隔,推进早期恶性瘤检测

Irem Nur Savas1, Abdurrahman Coskun2

  • 1Department of Biochemistry and Molecular Biology, Institute of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Istanbul 34752, Turkey.

Biomolecules
|July 29, 2025
PubMed
概括

早期癌症检测需要改进瘤标志物策略. 本综述探讨了新的生物标志物,生物传感器的持续监测,以及为更有效的诊断和治疗提供个性化解释.